MARSHALL INVESTMENT MANAGEMENT, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2022427
LITTLETON, CO
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,364
New position
Shares Held
7
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,267
of 1,322 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL INVESTMENT MANAGEMENT, LLC holds $11,814 across 2 Biotechnology names. REGN ranks #2 (36.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15 | $7,450 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
7 | $4,364 |
All Filings in REGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,364 | 7 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||